Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
BACKGROUND: Transthyretin amyloid cardiomyopathy (ATTR-CM) is a frequently underdiagnosed disease in which delay in diagnosis limits the efficacy of treatments. Artificial intelligence (AI) applied to standard 12-lead electrocardiograms (ECGs) is promising and may help improve ATTR-CM early detection. OBJECTIVES: The goals of this study were to extend the Willem AI cloud platform for ATTR-CM detec...
This study investigates the application of machine learning (ML) techniques combined with neuroimaging and speech signal processing for the early detection of neurological disorders, including Alzheimer's disease, Parkinson's disease, and epilepsy. A multisource analysis dataset consisting of neuro-images and speech features was utilized to train and evaluate various ML classifiers, such as K-near...
BackgroundEye movement is a vital indicator of neurodegenerative diseases, brain health, and behavior. However, existing knowledge is limited to patie...
Alzheimer's disease (AD) is a progressive neurodegenerative disease of the nervous system, which has become an important public health issue attractin...
BACKGROUND: As the global population continues to age, the prevalence of geriatric conditions, including dementia and frailty, is also increasing. Ear...
Dementia is a growing global health challenge, with the majority of individuals living with dementia receiving care from family members. However, many...
OBJECTIVE: Alzheimer's disease, a progressive neurodegenerative disorder, involves neural, genetic, and proteomic factors and impacts multiple cogniti...
Population aging worldwide has intensified the need to understand how mental health in later life is shaped by both cultural norms and structural syst...
BACKGROUND AND PURPOSE: Electroencephalogram (EEG) signals play a vital role in analyzing neurological activity and diagnosing various neurological di...
Profiling imaging biomarkers of prodromal Alzheimer's disease (AD) against AD dementia may aid earlier diagnosis, yet approaches jointly capturing iro...
Alzheimer's disease (AD) is pressing global health concerns, for which early diagnosis is critical to effective intervention. However, conventional ap...
Co-pathology is a common feature of neurodegenerative diseases that complicates diagnosis, treatment and clinical management. However, sensitive, spec...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline, amyloid-β plaques, and neurofibrillary tangle...
BackgroundAlzheimer's disease (AD) involves progressive cognitive decline associated with disrupted coordination and information exchange across brain...
BackgroundDementia is a common complication of type 2 diabetes mellitus (T2DM), influenced by both genetic susceptibility and social disadvantages. Wh...
Parkinson's disease (PD) affects 10Â million globally, with accurate staging essential for personalized treatment planning. Current UPDRS assessments a...
Quantitative PET underpins diagnosis and treatment monitoring in neurodegenerative disease, yet systematic biases between PET-MRI and PET-CT preclude ...
Large-scale combat operations (LSCOs) impose major constraints on battlefield medical systems, combining sustained casualty inflow, degraded communica...
BACKGROUND: Second-generation antipsychotics (SGAs) are frequently used off-label to manage behavioral symptoms in Alzheimer's disease (AD), despite o...